Summary
MabVax Therapeutics Holdings Inc. (MabVax Therapeutics) formerly known as Telik, Inc. is a development stage bio pharmaceutical company that carries out discovery, development and commercialization of vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. The company's research and development activities are focused on advancing its clinical advanced drug candidates, under the antibody and vaccine programs. The antibody product candidates for 5B1 antibody program, 5B1 antibody drug conjugate, 5B1 Imaging program, and 1B7 and 31F9 antibody program. The company’s vaccine programs candidates for bivalent vaccine, trivalent vaccine, pentavalent vaccine and multiple vaccines. The company has partnerships with academic institutions and also with pharmaceutical and biotechnology companies. MabVax Therapeutics is headquartered in San Diego, California, the US.
MabVax Therapeutics Holdings, Inc. (MBVX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
MabVax Therapeutics Holdings, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
MabVax Therapeutics Holdings, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
MabVax Therapeutics Holdings, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
MabVax Therapeutics Holdings, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
MabVax Therapeutics Holdings, Inc., Medical Devices Deals, 2010 to YTD 2016 9
MabVax Therapeutics Holdings, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
MabVax Therapeutics Holdings, Inc., Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Telik Raises USD5 Million in Venture Financing 12
Telik Raises USD4.6 Million in Venture Financing 13
Mabvax Therapeutics Raises US$12 Million In Venture Financing 14
MabVax Therapeutics Raises US$5.2 Million In First Tranche Of Series B Financing 15
Partnerships 16
MabVax Therapeutics Enters into Research Agreement with Rockefeller University 16
MabVax Therapeutics Enters into Co-development Agreement with Memorial Sloan Kettering Cancer Center 17
Licensing Agreements 18
MabVax Therapeutics Enters into Licensing Agreement with Life Technologies 18
MabVax Therapeutics Enters into Option for Licensing Agreement with Juno Therapeutics 19
Memorial Sloan Kettering Cancer Center Enters into Licensing Agreement with MabVax Therapeutics 20
Equity Offering 21
MabVax Therapeutics Raises USD2.75 Million in Public Offering of Shares 21
MabVax Therapeutics Raises USD11.6 Million in Private Placement of Units 22
MabVax Therapeutics Raises USD3 Million in Private Placement of Shares 24
MabVax Therapeutics Raises USD1.5 Million in Private Placement of Shares upon Exercise of Warrants 25
MabVax Therapeutics Raises USD1.5 Million in Private Placement of Shares upon Exercise of Warrants 26
MabVax Therapeutics Raises USD2.5 Million in Private Placement of Shares 27
MabVax Therapeutics Raises Funds through Private Placement of Shares upon Exercise of Warrants 28
Telik Completes Private Placement Of Shares For US$0.2 Million 29
Acquisition 31
Telik Completes Acquisition of MabVax Therapeutics, Oncology Therapies Provider 31
MabVax Therapeutics Holdings, Inc. - Key Competitors 33
Key Employees 34
Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36
List of Tables
MabVax Therapeutics Holdings, Inc., Pharmaceuticals & Healthcare, Key Facts, 2014 1
MabVax Therapeutics Holdings, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
MabVax Therapeutics Holdings, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
MabVax Therapeutics Holdings, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
MabVax Therapeutics Holdings, Inc., Deals By Therapy Area, 2010 to YTD 2016 8
MabVax Therapeutics Holdings, Inc., Medical Devices Deals, 2010 to YTD 2016 9
MabVax Therapeutics Holdings, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Telik Raises USD5 Million in Venture Financing 12
Telik Raises USD4.6 Million in Venture Financing 13
Mabvax Therapeutics Raises US$12 Million In Venture Financing 14
MabVax Therapeutics Raises US$5.2 Million In First Tranche Of Series B Financing 15
MabVax Therapeutics Enters into Research Agreement with Rockefeller University 16
MabVax Therapeutics Enters into Co-development Agreement with Memorial Sloan Kettering Cancer Center 17
MabVax Therapeutics Enters into Licensing Agreement with Life Technologies 18
MabVax Therapeutics Enters into Option for Licensing Agreement with Juno Therapeutics 19
Memorial Sloan Kettering Cancer Center Enters into Licensing Agreement with MabVax Therapeutics 20
MabVax Therapeutics Raises USD2.75 Million in Public Offering of Shares 21
MabVax Therapeutics Raises USD11.6 Million in Private Placement of Units 22
MabVax Therapeutics Raises USD3 Million in Private Placement of Shares 24
MabVax Therapeutics Raises USD1.5 Million in Private Placement of Shares upon Exercise of Warrants 25
MabVax Therapeutics Raises USD1.5 Million in Private Placement of Shares upon Exercise of Warrants 26
MabVax Therapeutics Raises USD2.5 Million in Private Placement of Shares 27
MabVax Therapeutics Raises Funds through Private Placement of Shares upon Exercise of Warrants 28
Telik Completes Private Placement Of Shares For US$0.2 Million 29
Telik Completes Acquisition of MabVax Therapeutics, Oncology Therapies Provider 31
MabVax Therapeutics Holdings, Inc., Key Competitors 33
MabVax Therapeutics Holdings, Inc., Key Employees 34
MabVax Therapeutics Holdings, Inc., Subsidiaries 35
List of Figures
MabVax Therapeutics Holdings, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
MabVax Therapeutics Holdings, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
MabVax Therapeutics Holdings, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
MabVax Therapeutics Holdings, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
MabVax Therapeutics Holdings, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
MabVax Therapeutics Holdings, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
MabVax Therapeutics Holdings, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
MabVax Therapeutics Holdings, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
MabVax Therapeutics Holdings, Inc., Medical Devices Deals, 2010 to YTD 2016 9
